Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
December 2016 onwards
Submit An Event
Events - May 2014
High Content Analysis
14 May 2014 - 15 May 2014 - Barcelona, Spain
SELECTBIO is pleased to present the 11th High Content Analysis conference, which will take place at the Fira Barcelona, on May 14th & 15th 2014. Featuring an array of leading international speakers, this event aims to provide you with an insight into the latest developments in high content technologies and their applications.
Hot topics to be covered include novel 3D cell based screening methods, the use of model organisms, and live cell imaging approaches. Focus will also be given to the evolving use of microfluidics in this field. Attending this event will provide you with excellent opportunities for networking with like-minded peers, helping you to find solutions and build collaborations.
Anthony Davies, Director, High Content Research Facility, National Center for High Content Screening and Analysis (INCHA)
Hakim Djaballah, Director, Memorial Sloan Kettering Cancer Center
Running alongside the High Content Analysis conference will be the ELA exhibition, covering the latest technological advances and associated services from leading solution providers within this field. Registered delegates will also have access to the following co-located conference tracks, ensuring a cost effective trip:
Advances in qPCR & dPCR
Advances in NGS & Big Data
, Advances in Automation & Robotics and
Advances in Cellular Assays & Cell Culture
You can present your research on a poster while attending the meeting.
Deadline: 02 May 2014
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Senor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Investigating ‘Black Box’ of Human Genetics
Investigations into inactive X chromosomes have shown unusual DNA repeat elements are essential for maintaining 3D structure.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,200+ scientific and medical posters
4,800+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!